This webinar will focus on arrythmia risk and rhythm management in HCM. This webinar is part of the Accelerating Innovation for Medical Excellence (AIME) in Hypertrophic Cardiomyopathy initiative, and will be moderated by Matthew W. Martinez, MD, FACC.

This webinar will focus on atrial and ventricular arrythmia risk and rhythm management in HCM. This webinar will highlight state-of-the-art approaches for diagnosis, management, and treatment of atrial and ventricular arrythmias in HCM. We will also discuss patient selection for medical and intervention therapies for those with atrial and ventricular arrythmias, including rhythm management, stroke prevention, and assessment of risk and prevention of sudden death. This webinar is part of the Accelerating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy initiative (AIME), and will be moderated by Matthew W. Martinez, MD, FACC. Atrial and ventricular arrythmias are common in HCM.

Key Objective/Learning Outcomes

1. Identify a guideline-driven approach for medical and intervention therapies for HCM related arrythmias.
2. Identify risks, benefits, and pitfalls with treatments for HCM related arrythmias.

Clinical Topics: Heart Failure and Cardiomyopathies

Keywords: